Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

12.73
Delayed Data
As of 11:41am ET
 -0.145 / -1.13%
Today’s Change
6.89
Today|||52-Week Range
22.22
-4.50%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 31.50, with a high estimate of 87.41 and a low estimate of 29.00. The median estimate represents a +147.45% increase from the last price of 12.73.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.55
Sales
$25.3K
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.79%
 
 
 
 
 
 
Growthannually -74.81%
 
 
 
 
 

Sales

Growthquarterly 2,425.00%
 
 
 
 
 
 
Growthannually -98.92%
 
 
 
 
 
Key to the earnings and sales forecast charts.